Patrys Limited (ASX:PAB)
0.0330
0.00 (0.00%)
Jan 30, 2026, 3:55 PM AEST
Patrys Revenue
In the fiscal year ending June 30, 2025, Patrys had annual revenue of 828.54K AUD, down -40.57%. Patrys had revenue of 98.08K in the half year ending June 30, 2025, a decrease of -90.44%.
Revenue
828.54K
Revenue Growth
-40.57%
P/S Ratio
13.57
Revenue / Employee
82.85K
Employees
10
Market Cap
11.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 828.54K | -565.62K | -40.57% |
| Jun 30, 2024 | 1.39M | -1.46M | -51.11% |
| Jun 30, 2023 | 2.85M | -481.67K | -14.45% |
| Jun 30, 2022 | 3.33M | 2.00M | 149.08% |
| Jun 30, 2021 | 1.34M | 565.53K | 73.18% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chimeric Therapeutics | 12.68M |
| Immuron | 7.29M |
| Tissue Repair | 2.63M |
| Neurotech International | 2.44M |
| Biotron | 1.81M |
| Acrux | 1.19M |
| AdAlta | 677.01K |
| Bio-Gene Technology | 524.37K |